Hathaway JT, Shah MP, Hathaway DB, Maryam Zekavat S, Krasniqi D, Gittinger JW, et al
With a broad consumer appeal around weight loss, a price much lower than the patent-protected versions, and no restrictions on marketing, compounded GLP-1s have been used by millions of patients, boosting a cottage industry providing direct-to-consumer semaglutide and other related products through telehealth companies and medical spas
Importantly, while incidence of IBD is still rising, the mortality is low and thus the prevalence of IBD escalates globally (Molodecky et al
Focus on value-based care models and real-world outcome data will shape future market dynamics and pricing structures